Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck CancerEben L. Rosenthal, Kurt R. Zinn, Jason M. Warram et al.|Clinical Cancer Research|2015Cited by 477
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced CancersPatricia LoRusso, Alejandro D. Ricart, Keith D. Wilner et al.|Clinical Cancer Research|2010Cited by 250
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025Robert I. Haddad, Bailee Sliker, Lindsay Bischoff et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 30
Does Integration of Induction Chemotherapy to Concurrent Chemotherapy and Radiotherapy Improve Outcomes for Locally Advanced Head and Neck Cancer? A Retrospective Comparison of Patients Treated on Prospective Clinical TrialsJ.J. Caudell, James A. Bonner, Sharon A. Spencer et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 0